EHealth Analyst Ratings
EHealth Analyst Ratings
電子健康分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 47.06% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 08/09/2023 | 13.12% | Citigroup | $9 → $10 | Maintains | Neutral |
| 08/09/2023 | 13.12% | Deutsche Bank | $5 → $10 | Maintains | Hold |
| 05/19/2023 | 47.06% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 05/15/2023 | 47.06% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 05/10/2023 | 13.12% | Credit Suisse | → $10 | Reiterates | → Neutral |
| 04/28/2023 | -20.81% | Citigroup | $10 → $7 | Maintains | Neutral |
| 03/08/2023 | 13.12% | Citigroup | $4.5 → $10 | Maintains | Neutral |
| 03/06/2023 | 47.06% | RBC Capital | $16 → $13 | Maintains | Sector Perform |
| 03/06/2023 | 13.12% | Credit Suisse | $4 → $10 | Maintains | Neutral |
| 08/15/2022 | 13.12% | Credit Suisse | $13 → $10 | Maintains | Neutral |
| 08/09/2022 | -9.5% | Truist Securities | $12 → $8 | Maintains | Hold |
| 08/09/2022 | 81% | RBC Capital | $17 → $16 | Maintains | Sector Perform |
| 05/04/2022 | 47.06% | Credit Suisse | $16 → $13 | Maintains | Neutral |
| 03/21/2022 | 69.68% | Citigroup | $37 → $15 | Downgrades | Buy → Neutral |
| 03/03/2022 | 81% | Credit Suisse | $31 → $16 | Maintains | Neutral |
| 03/02/2022 | 69.68% | Truist Securities | → $15 | Downgrades | Buy → Hold |
| 03/02/2022 | 69.68% | Evercore ISI Group | $35 → $15 | Downgrades | Outperform → In-Line |
| 01/07/2022 | 250.68% | Credit Suisse | $45 → $31 | Downgrades | Outperform → Neutral |
| 12/20/2021 | 318.55% | Citigroup | $45 → $37 | Maintains | Buy |
| 11/29/2021 | 114.93% | Deutsche Bank | $86 → $19 | Maintains | Hold |
| 11/10/2021 | 409.05% | Credit Suisse | $59 → $45 | Maintains | Outperform |
| 11/09/2021 | 273.3% | Craig-Hallum | → $33 | Downgrades | Buy → Hold |
| 11/09/2021 | 216.74% | RBC Capital | $62 → $28 | Maintains | Sector Perform |
| 07/30/2021 | 601.36% | RBC Capital | $70 → $62 | Maintains | Sector Perform |
| 07/30/2021 | 748.42% | Credit Suisse | $90 → $75 | Maintains | Outperform |
| 04/30/2021 | 918.1% | Credit Suisse | $78 → $90 | Maintains | Outperform |
| 03/25/2021 | 612.67% | Goldman Sachs | → $63 | Downgrades | Buy → Neutral |
| 03/23/2021 | 804.98% | Evercore ISI Group | $60 → $80 | Maintains | Outperform |
| 02/19/2021 | 612.67% | Deutsche Bank | → $63 | Downgrades | Buy → Hold |
| 02/02/2021 | 623.98% | Goldman Sachs | $101 → $64 | Maintains | Buy |
| 02/01/2021 | 635.29% | Craig-Hallum | $150 → $65 | Maintains | Buy |
| 02/01/2021 | 1031.22% | Truist Securities | $200 → $100 | Maintains | Buy |
| 02/01/2021 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 12/14/2020 | 1087.78% | SVB Leerink | $110 → $105 | Maintains | Outperform |
| 09/25/2020 | 1042.53% | Goldman Sachs | → $101 | Initiates Coverage On | → Buy |
| 09/08/2020 | 1144.34% | SVB Leerink | → $110 | Upgrades | Market Perform → Outperform |
| 07/27/2020 | 1200.9% | Raymond James | $165 → $115 | Maintains | Outperform |
| 07/24/2020 | 1664.71% | Credit Suisse | $174 → $156 | Maintains | Outperform |
| 07/24/2020 | 1483.71% | Barclays | $150 → $140 | Maintains | Overweight |
| 07/24/2020 | 1144.34% | SVB Leerink | $108 → $110 | Maintains | Market Perform |
| 07/14/2020 | 1427.15% | Citigroup | → $135 | Initiates Coverage On | → Buy |
| 07/01/2020 | 1121.72% | SVB Leerink | → $108 | Initiates Coverage On | → Market Perform |
| 04/27/2020 | 1823.08% | Deutsche Bank | $177 → $170 | Maintains | Buy |
| 04/16/2020 | 1596.83% | Barclays | → $150 | Initiates Coverage On | → Overweight |
| 02/24/2020 | 1924.89% | Credit Suisse | $145 → $179 | Maintains | Outperform |
| 02/24/2020 | 2728.05% | SunTrust Robinson Humphrey | $200 → $250 | Maintains | Buy |
| 02/21/2020 | 1902.26% | Deutsche Bank | $163 → $177 | Maintains | Buy |
| 02/21/2020 | 1777.83% | RBC Capital | $132 → $166 | Maintains | Outperform |
| 02/21/2020 | 1992.76% | Cantor Fitzgerald | $150 → $185 | Reiterates | → Overweight |
| 01/28/2020 | 1427.15% | Raymond James | $90 → $135 | Maintains | Outperform |
| 01/24/2020 | 1393.21% | RBC Capital | $111 → $132 | Maintains | Outperform |
| 01/24/2020 | 1596.83% | Craig-Hallum | $110 → $150 | Maintains | Buy |
| 01/24/2020 | 1540.27% | Credit Suisse | $134 → $145 | Maintains | Outperform |
| 01/24/2020 | 1596.83% | Cantor Fitzgerald | $120 → $150 | Reiterates | → Overweight |
| 10/15/2019 | 918.1% | Raymond James | → $90 | Initiates Coverage On | → Outperform |
| 09/12/2019 | 1857.01% | Deutsche Bank | → $173 | Initiates Coverage On | → Buy |
| 08/06/2019 | 1438.46% | Credit Suisse | $118 → $136 | Maintains | Outperform |
| 07/29/2019 | — | First Analysis | Upgrades | Outperform → Strong Buy | |
| 07/26/2019 | 1257.47% | Cantor Fitzgerald | $100 → $120 | Maintains | Overweight |
| 07/10/2019 | — | Credit Suisse | Initiates Coverage On | → Outperform | |
| 05/08/2019 | 1031.22% | Cantor Fitzgerald | $87 → $100 | Maintains | Overweight |
| 02/04/2019 | 748.42% | Evercore ISI Group | → $75 | Initiates Coverage On | → Outperform |
| 12/20/2018 | 544.8% | RBC Capital | → $57 | Initiates Coverage On | → Outperform |
| 08/16/2018 | 352.49% | Chardan Capital | → $40 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 47.06% | 加拿大皇家銀行資本 | →$13 | 重申 | 扇區表現→扇區表現 |
| 08/09/2023 | 13.12% | 花旗集團 | $9→$10 | 維護 | 中性 |
| 08/09/2023 | 13.12% | 德意志銀行 | $5→$10 | 維護 | 保持 |
| 2023年05月19日 | 47.06% | 加拿大皇家銀行資本 | →$13 | 重申 | 扇區表現→扇區表現 |
| 2023年05月15日 | 47.06% | 加拿大皇家銀行資本 | →$13 | 重申 | 扇區表現→扇區表現 |
| 2023年05月10日 | 13.12% | 瑞士信貸 | →$10 | 重申 | →中性 |
| 04/28/2023 | -20.81% | 花旗集團 | $10→$7 | 維護 | 中性 |
| 03/08/2023 | 13.12% | 花旗集團 | $4.5→$10 | 維護 | 中性 |
| 03/06/2023 | 47.06% | 加拿大皇家銀行資本 | $16→$13 | 維護 | 行業表現 |
| 03/06/2023 | 13.12% | 瑞士信貸 | $4→$10 | 維護 | 中性 |
| 2022年08月15日 | 13.12% | 瑞士信貸 | $13→$10 | 維護 | 中性 |
| 08/09/2022 | -9.5% | Truist證券 | $12→$8 | 維護 | 保持 |
| 08/09/2022 | 百分之八十一 | 加拿大皇家銀行資本 | $17→$16 | 維護 | 行業表現 |
| 05/04/2022 | 47.06% | 瑞士信貸 | $16→$13 | 維護 | 中性 |
| 03/21/2022 | 69.68% | 花旗集團 | $37→$15 | 評級下調 | 購買→中性 |
| 03/03/2022 | 百分之八十一 | 瑞士信貸 | $31→$16 | 維護 | 中性 |
| 03/02/2022 | 69.68% | Truist證券 | →$15 | 評級下調 | 購買→Hold |
| 03/02/2022 | 69.68% | Evercore ISI集團 | $35→$15 | 評級下調 | 勝過→同線 |
| 01/07/2022 | 250.68% | 瑞士信貸 | $45→$31 | 評級下調 | 跑贏→中性 |
| 12/20/2021 | 318.55% | 花旗集團 | $45→$37 | 維護 | 買 |
| 2021年11月29日 | 114.93% | 德意志銀行 | $86→$19 | 維護 | 保持 |
| 2021年11月10日 | 409.05% | 瑞士信貸 | $59→$45 | 維護 | 跑贏大盤 |
| 11/09/2021 | 273.3% | 克雷格-哈勒姆 | →$33 | 評級下調 | 購買→Hold |
| 11/09/2021 | 216.74% | 加拿大皇家銀行資本 | $62→$28 | 維護 | 行業表現 |
| 07/30/2021 | 601.36% | 加拿大皇家銀行資本 | $70→$62 | 維護 | 行業表現 |
| 07/30/2021 | 748.42% | 瑞士信貸 | $90→$75 | 維護 | 跑贏大盤 |
| 04/30/2021 | 918.1% | 瑞士信貸 | $78→$90 | 維護 | 跑贏大盤 |
| 03/25/2021 | 612.67% | 高盛 | →$63 | 評級下調 | 購買→中性 |
| 03/23/2021 | 804.98% | Evercore ISI集團 | $60→$80 | 維護 | 跑贏大盤 |
| 02/19/2021 | 612.67% | 德意志銀行 | →$63 | 評級下調 | 購買→Hold |
| 02/02/2021 | 623.98% | 高盛 | $101→$64 | 維護 | 買 |
| 02/01/2021 | 635.29% | 克雷格-哈勒姆 | $150→$65 | 維護 | 買 |
| 02/01/2021 | 1031.22% | Truist證券 | $200→$100 | 維護 | 買 |
| 02/01/2021 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
| 12/14/2020 | 1087.78% | SVB Leerink | $110→$105 | 維護 | 跑贏大盤 |
| 09/25/2020 | 1042.53% | 高盛 | →$101 | 開始承保 | →購買 |
| 09/08/2020 | 1144.34% | SVB Leerink | →$110 | 升級 | 市場表現優於→ |
| 07/27/2020 | 1200.9% | 雷蒙德·詹姆斯 | $165→$115 | 維護 | 跑贏大盤 |
| 07/24/2020 | 1664.71% | 瑞士信貸 | $174→$156 | 維護 | 跑贏大盤 |
| 07/24/2020 | 1483.71% | 巴克萊 | $150→$140 | 維護 | 超重 |
| 07/24/2020 | 1144.34% | SVB Leerink | $108→$110 | 維護 | 市場表現 |
| 07/14/2020 | 1427.15% | 花旗集團 | →$135 | 開始承保 | →購買 |
| 07/01/2020 | 1121.72% | SVB Leerink | →$108 | 開始承保 | →市場表現 |
| 04/27/2020 | 1823.08% | 德意志銀行 | $177→$170 | 維護 | 買 |
| 04/16/2020 | 1596.83% | 巴克萊 | →$150 | 開始承保 | →超重 |
| 02/24/2020 | 1924.89% | 瑞士信貸 | $145→$179 | 維護 | 跑贏大盤 |
| 02/24/2020 | 2728.05% | SunTrust Robinson Humphrey | $200→$250 | 維護 | 買 |
| 02/21/2020 | 1902.26% | 德意志銀行 | $163→$177 | 維護 | 買 |
| 02/21/2020 | 1777.83% | 加拿大皇家銀行資本 | $132→$166 | 維護 | 跑贏大盤 |
| 02/21/2020 | 1992.76% | 康託·菲茨傑拉德 | $150→$185 | 重申 | →超重 |
| 1/28/2020 | 1427.15% | 雷蒙德·詹姆斯 | $90→$135 | 維護 | 跑贏大盤 |
| 1/24/2020 | 1393.21% | 加拿大皇家銀行資本 | $111→$132 | 維護 | 跑贏大盤 |
| 1/24/2020 | 1596.83% | 克雷格-哈勒姆 | $110→$150 | 維護 | 買 |
| 1/24/2020 | 1540.27% | 瑞士信貸 | $134→$145 | 維護 | 跑贏大盤 |
| 1/24/2020 | 1596.83% | 康託·菲茨傑拉德 | $120→$150 | 重申 | →超重 |
| 2019年10月15日 | 918.1% | 雷蒙德·詹姆斯 | →$90 | 開始承保 | →跑贏大盤 |
| 2019/12/09 | 1857.01% | 德意志銀行 | →$173 | 開始承保 | →購買 |
| 2019年08月06日 | 1438.46% | 瑞士信貸 | $118→$136 | 維護 | 跑贏大盤 |
| 2019年07月29日 | - | 第一次分析 | 升級 | 跑贏→強勢買入 | |
| 2019年07月26日 | 1257.47% | 康託·菲茨傑拉德 | $100→$120 | 維護 | 超重 |
| 2019年07月10日 | - | 瑞士信貸 | 開始承保 | →跑贏大盤 | |
| 2019年08月05日 | 1031.22% | 康託·菲茨傑拉德 | $87→$100 | 維護 | 超重 |
| 2019年02月04日 | 748.42% | Evercore ISI集團 | →$75 | 開始承保 | →跑贏大盤 |
| 2018年12月20日 | 544.8% | 加拿大皇家銀行資本 | →$57 | 開始承保 | →跑贏大盤 |
| 2018年08月16日 | 352.49% | 查爾丹資本 | →$40 | 開始承保 | →購買 |
What is the target price for eHealth (EHTH)?
EHealth(EHTH)的目標價格是多少？
The latest price target for eHealth (NASDAQ: EHTH) was reported by RBC Capital on August 14, 2023. The analyst firm set a price target for $13.00 expecting EHTH to rise to within 12 months (a possible 47.06% upside). 11 analyst firms have reported ratings in the last year.
加拿大皇家銀行資本於2023年8月14日報道了eHealth(納斯達克：EHTH)的最新目標價。這家分析公司將目標價定為13.00美元，預計EHTH將在12個月內上漲(可能上漲47.06%)。過去一年，有11家分析公司公佈了評級。
What is the most recent analyst rating for eHealth (EHTH)?
EHealth(EHTH)的最新分析師評級是多少？
The latest analyst rating for eHealth (NASDAQ: EHTH) was provided by RBC Capital, and eHealth reiterated their sector perform rating.
EHealth(納斯達克代碼：EHTH)的最新分析師評級是由加拿大皇家銀行資本提供的，eHealth重申了其行業表現評級。
When is the next analyst rating going to be posted or updated for eHealth (EHTH)?
EHealth(EHTH)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of eHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for eHealth was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與eHealth的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。EHealth的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating eHealth (EHTH) correct?
分析師對eHealth(EHTH)的評級正確嗎？
While ratings are subjective and will change, the latest eHealth (EHTH) rating was a reiterated with a price target of $0.00 to $13.00. The current price eHealth (EHTH) is trading at is $8.84, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的電子健康(EHTH)評級被重申，目標價在0.00美元至13.00美元之間。EHealth目前的交易價格為8.84美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。